Condition
Osteochondral Defects
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Unknown1
Terminated1
Clinical Trials (2)
Showing 2 of 2 trials
NCT01209390TerminatedPrimary
A Prospective, Post-marketing Registry on the Use of ChondroMimetic for the Repair of Osteochondral Defects
NCT00891501Phase 2Unknown
The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects
Showing all 2 trials